Elite Pharmaceuticals Inc (ELTP) bonds
ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Elite Pharmaceuticals reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Mar 31, 2022
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Elite Pharmaceuticals's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Matures | Amount issued | Carrying value |
|---|---|---|---|---|
| Njeda Bonds Series A Notes | 6.50% | Sep 1, 2030 | $3.66M | – |
| Loans Payable | – | – | – | $2.22M |
| NJEDA Bonds | – | – | – | $850.00K |
| Njeda Bonds Noncurrent | – | – | – | $655.10K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?